Computed tomography and magnetic resonance imaging evaluation of liver cancer

Gastroenterology Clinics of North America

Volumn 31, Issue 3, 2002, Pages 759-776

  Harisinghani, Mukesh G ^a   Hahn, Peter F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADODIAMIDE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; GADOTERIDOL; MANGAFODIPIR; SUPERPARAMAGNETIC IRON OXIDE;

ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; ECHOGRAPHY; EVALUATION; HUMAN; LIVER ADENOMA; LIVER CANCER; LIVER CELL CARCINOMA; LIVER HEMANGIOMA; LIVER METASTASIS; LIVER TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

ADENOMA, LIVER CELL; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CONTRAST MEDIA; HEMANGIOMA; HUMANS; LIVER NEOPLASMS; LYMPHOMA; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036759620     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(02)00028-6     Document Type: Review

References (43)

1. Craig J, Peters R, Edmondson H. Tumors of liver and intrahepatic bile ducts. In: Craig J, Peters R, Edmondson H, editors. Atlas of Tumor Pathology 1989;vol. 2 series: Washington, DC: Armed Forces Institute of Pathology; 1989.
2. Rummeny EJ, Marchal G. Liver imaging. Clinical applications and future perspectives. Acta Radiol 1997;38:626-30.
3. Silverman PM, Malley J, Tefft MC, et al. Conspicuity of hepatic metastases on helical CT: Effect of different time delays between contrast administration and scanning. AJR Am J Roentgenol 1995;164:619-23.
4. van Leeuwen MS, Noordzij J, Feldberg MA, et al. Focal liver lesions: Characterization with triphasic spiral CT. Radiology 1996;201:327-36.
5. Hu H. Multi-slice helical CT: Scan and reconstruction. Med Phys 1999;26:5-18.
6. Paulson EK. Evaluation of the liver for metastatic disease. Semin Liver Dis 2001;21:225-36.
7. Wong K, Paulson EK, Nelson RC. Breath-hold three dimensional CT of the liver with multidetector row helical CT. Radiology 2001;219:75-9.
8. Rydberg J, Buckwalter KA, Caldemeyer KS, et al. Multisection CT: Scanning techniques and clinical applications. Radiographics 2000;20:1787-806.
9. Rummeny EJ, Wernecke K, Saini S, et al. Comparison between high-field-strength MR imaging and CT for screening of hepatic metastases: A receiver operating characteristic analysis. Radiology 1992;182:879-86.
10. Semelka RC, Cance WG, Marcos HB, et al. Liver metastases: Comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology 1999;213:86-91.
11. Semelka RC, Shoenut JP, Kroeker MA, et al. Focal liver disease: Comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T. Radiology 1992;184:687-94.
12. Vogl TJ, Hammerstingl R, Schwarz W, et al. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 1996;198:881-7.
13. Rummeny EJ, Torres CG, Kurdziel JC, et al. MnDPDP for MR imaging of the liver. Results of an independent image evaluation of the European phase III studies. Acta Radiol 1997;38:638-42.
14. Ackerman N, Lien W, Kondi E, et al. The blood supply of experimental liver metstases. Distribution of hepatic artery and portal vein blood to "small" and "large" tumors. Surgery 1969;66:1067-72.
15. Robinson PJ. Imaging liver metastases: Current limitations and future prospects. Br J Radiol 2000;73:234-41.
16. Ward J, Naik KS, Guthrie JA, et al. Hepatic lesion detection: Comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 1999;210:459-66.
17. Leslie DF, Johnson CD, Johnson CM, et al. Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: Value of contrast enhancement patterns. AJR Am J Roentgenol 1995;164:625-9.
18. Leslie DF, Johnson CD, MacCarty RL, et al. Single-pass CT of hepatic tumors: Value of globular enhancement in distinguishing hemangiomas from hypervascular metastases. AJR Am J Roentgenol 1995;165:1403-6.
19. Sica GT, Ji H, Ros PR. CT and MR imaging of hepatic metastases. AJR Am J Roentgenol 2000;174:691-8.
20. Kelekis NL, Semelka RC, Woosley JT. Malignant lesions of the liver with high signal intensity on T1-weighted MR images. J Magn Reson Imaging 1996;6:291-4.
21. Mahfouz AE, Hamm B, Wolf KJ. Peripheral washout: A sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 1994;190:49-52.
22. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9.
23. Oliver JH III, Baron RL, Federle M, et al. Detecting hepatocellular carcinoma: Value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast enhanced CT imaging. AJR Am J Roentgenol 1996;167:71-7.
24. Bartolozzi C, Lencioni R, Donati F, et al. Abdominal MR: Liver and pancreas. Eur Radiol 1999;9:1496-512.
25. Fujita T, Honjo K, Ito K, et al. High-resolution dynamic MR imaging of hepatocellular carcinoma with a phased-array body coil. Radiographics 1997;17:315-31.
26. Itoh K, Nishimura K, Togashi K, et al. Hepatocellular carcinoma: MR imaging. Radiology 1987;164:21-5.
27. Krinsky GA, Lee VS, Theise ND. Focal lesions in the cirrhotic liver: High resolution ex vivo MRI with pathologic correlation. J Comput Assist Tomogr 2000;24:189-96.
28. Hytiroglou P, Theise ND. Differential diagnosis of hepatocellular nodular lesions. Semin Diagn Pathol 1998;15:285-99.
29. Nakanuma Y, Terada T, Ueda K, et al. Adenomatous hyperplasia of the liver as a precancerous lesion. Liver 1993;13:1-9.
30. Mitchell DG, Rubin R, Siegelman ES, et al. Hepatocellular carcinoma within siderotic regenerative nodules: Appearance as a nodule within a nodule on MR images. Radiology 1991;178:101-3.
31. Corrigan K, Semelka RC. Dynamic contrast-enhanced MR imaging of fibrolamellar hepatocellular carcinoma. Abdom Imaging 1995;20:122-5.
32. Ichikawa T, Federle MP, Grazioli L, et al. Hepatocellular adenoma: Multiphasic CT and histopathologic findings in 25 patients. Radiology 2000;214:861-8.
33. Arrivé L, Flejou JF, Vilgrain V, et al. Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 1994;193:507-12.
34. Flejou JF, Barge J, Menu Y, et al. Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology 1985;89:1132-8.
35. Choi BI, Han JK, Kim YI, et al. Combined hepatocellular and cholangiocarcinoma of the liver: Sonography, CT, angiography, and iodized-oil CT with pathologic correlation. Abdom Imaging 1994;19:43-6.
36. Yoshimitsu K, Honda H, Kaneko K, et al. MR signal intensity changes in hepatic parenchyma with ductal dilation caused by intrahepatic cholangiocarcinoma. J Magn Reson Imaging 1997;7:136-41.
37. Zhang Y, Uchida M, Abe T, et al. Intrahepatic peripheral cholangiocarcinoma: Comparison of dynamic CT and dynamic MRI. J Comput Assist Tomogr 1999;23:670-7.
38. Busi Rizzi E, Schinina V, Cristofaro M, et al. Non-Hodgkin's lymphoma of the liver in patients with AIDS: Sonographic, CT, and MRI findings. J Clin Ultrasound 2001;29:125-9.
39. Gazelle GS, Lee MJ, Hahn PF, et al. US, CT, and MRI of primary and secondary liver lymphoma. J Comput Assist Tomogr 1994;18:412-5.
40. Maher MM, McDermott SR, Fenlon HM, et al. Imaging of primary non-Hodgkin's lymphoma of the liver. Clin Radiol 2001;56:295-301.
41. Fukuya T, Honda H, Murata S, et al. MRI of primary lymphoma of the liver. J Comput Assist Tomogr 1993;17:596-8.
42. Soyer P, Van Beers B, Grandin C, et al. Primary lymphoma of the liver: MR findings. Eur J Radiol 1993;16:209-12.
43. Weissleder R, Stark DD, Elizondo G, et al. MRI of hepatic lymphoma. Magn Reson Imaging 1988;6:675-81.